| CRISPR Medicine | This is an overview of our news stories
Some of the best links we picked up around the internet
Last week, Allogene Therapeutics announced the publication of data from the Phase 1 UNIVERSAL trial of ALLO-715, a TALEN-engineered CAR-T candidate...
Professor Stephanie Cherqui of University of California San Diego’s School of Medicine recently received a prestigious grant from the Californian...
In this clinical update, we look at four ongoing clinical trials involving a gene-edited therapeutic candidate for the treatment of solid cancers.
To mark the start of 2023, we look back on some of the key advances in gene-editing clinical trials from 2022.
